In this dynamic video review, Dr Daemen and Prof Van Mieghem cover the top late-breaking science, offering insight into how they will incorporate the data into their clinical practice.
What are the top trials of EuroPCR 2023? What are the considerations for practice? What is next?
00:44: EBC TWO 5-Year Follow-Up
00:59: EBC Main 3-Year Follow-Up
01:33: KISS Trial
03:53: Repeat TAVR
05:24: Chimney Stenting vs BASILICA to Prevent TAVR-related Coronary Obstruction
08:36: Prospective MITRAL Trial
11:32: FAST-TAVI II
18:30: TRANSFORM I
22:15: ABSORB IV
25:31: FAME III
Get a critical review of the EuroPCR 2023 late-breaking and featured data!
Watch our full EuroPCR 2023 late-breaking science coverage.